Rubius Therapeutics, Inc.

As the US is making life harder for biotechs and big pharma alike by reducing funding for basic science research, rolling out drug pricing reforms and shrinking the Food and Drug Administration, the U

Flagship Pioneering, the biopharma start-up creation firm behind Moderna , is broadening its horizon beyond its base in Cambridge, MA. It unveiled a new alliance with the UK government in London on 2

Jason Gardner is just a month into his role as CEO of Ampersand Biomedicines , one of the latest companies to emerge from Flagship Pioneering , but is nevertheless confident it can deliver a “new pa

The ongoing reckoning among biopharmaceutical companies that are running out of cash and unable to raise new funds – either because of a lack of near-term upcoming milestones or missed milestones – is